Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3025670 | Seminars in Thoracic and Cardiovascular Surgery | 2008 | 8 Pages |
Abstract
Primary graft dysfunction continues to be a major contributing factor to morbidity and mortality after lung transplantation. This condition is presumed to be the result of ischemia-reperfusion injury, which is associated with the release of endogenous substances that can activate the innate immune system. Primary graft dysfunction has been shown to be an independent risk factor for the development of bronchiolitis obliterans syndrome indicating that it can shape alloimmune responses. In this review, we focus on the classification, pathogenesis, possible prevention strategies, management and consequences of primary graft dysfunction.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yvette M. Carter, Andrew E. Gelman, Daniel Kreisel,